Cernostics’ paper describes a biomarker imaging approach, TissueCypher™, that quantifies key components of biopsies such as those found in cancer and pre-cancer conditions. Read more: http://bit.ly/1K6FXIi
Client & Alumni News
Cernostics’ paper describes a biomarker imaging approach, TissueCypher™, that quantifies key components of biopsies such as those found in cancer and pre-cancer conditions. Read more: http://bit.ly/1K6FXIi